Simvastatin and MS: The Lancet Neurology: August 2017
The Lancet Neurology in conversation with - A podcast by The Lancet Group - Thursdays

Categories:
Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv